Politics

The Aduhelm Files Damian Garde and Adam Feuerstein

STAT Plus: Seeking maximum profits, Biogen set an ‘unjustifiably high price’ for Alzheimer’s treatment, investigation finds

Health Sarah Owermohle

STAT Plus: New FDA guidance explains that Plan B is not an abortion pill

D.C. Diagnosis Rachel Cohrs

After nine months, an update on NIH’s long Covid research

Politics Rachel Cohrs

Pandemic response gets a permanent new home at the White House

Health Tech Mario Aguilar

STAT Plus: Medicare’s home hospital program may soon get a lifeline from Congress. Can it prove its worth?

Hospitals Tara Bannow

STAT Plus: Biden admin shares ownership data for thousands of hospitals, improving transparency about private equity’s stake

Politics Sarah Owermohle

STAT Plus: Amid dire maternal mortality rates, Congress falls short on Medicaid postpartum care

Politics Nicholas Florko

STAT Plus: Audit of FDA’s tobacco oversight underscores agency’s struggle to regulate the booming vaping market

Politics Rachel Cohrs and Sarah Owermohle

Congress reaches major health policy deal on Medicare, Medicaid, and pandemic preparedness

Politics Rachel Cohrs and Sarah Owermohle

STAT Plus: AbbVie exits major pharmaceutical industry lobbying groups

Politics Sarah Owermohle

STAT Plus: New Biden changes to Obamacare coverage for generics splits the industry

Politics Bob Herman

STAT Plus: Medicare chief: ‘Door is really open’ on coverage for new Alzheimer’s drug

Politics Rachel Cohrs

Walensky says CDC needs more authority from Congress to collect public health data

Politics Rachel Cohrs and Sarah Owermohle

STAT Plus: Congress has a chance to close the FDA’s Theranos loophole

Politics Sarah Owermohle

STAT Plus: ARPA-H’s new director wants to go on a hiring spree

Politics John Wilkerson

STAT Plus: FDA chief calls agency’s food program ‘under-supported, under-resourced’

Health Lev Facher

STAT Plus: Congress has its sights set too low on addiction, advocates charge

Exclusive John Wilkerson

STAT Plus: AAM’s Dan Leonard, president of generic drug lobby, ousted

Politics Sara Burnett — Associated Press

STAT Plus: Abortion rights groups look to next fights after 2022 wins

Health Lev Facher

Resistance to FDA’s opioid-disposal plan raises concerns about CADCA, a powerful advocacy group

Special Report Rachel Cohrs

STAT Plus: PhRMA, once invincible in Washington, has lost its edge

Politics Bob Herman

STAT Plus: Patient groups push federal government to enforce health care price estimates

Politics Rachel Cohrs

In a Republican-led House, probing science agencies tops the agenda

Politics Eric Boodman

STAT Plus: Chelsea Clinton on abortion care and the connection between democracy and women’s health

Politics Sarah Owermohle

STAT Plus: White House science adviser Alondra Nelson on the midterms, the cancer moonshot, and a book in the works

Politics Nicholas Florko

STAT Plus: The FDA has banned certain vapes and medicines. We still bought these 13 products in its backyard

Politics Rachel Cohrs

A Democratic Senate improves the outlook for Biden health and science priorities, including key nominees

Politics Olivia Goldhill

STAT Plus: Colorado becomes second state with legalized ‘medicinal psychedelics’

Politics Sarah Owermohle

STAT Plus: Michigan, Vermont, and California affirm abortion rights, as Kentucky voters shoot down anti-abortion amendment